These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 4399889)

  • 21. Comparison of the symptomatic, electrocardiographic and haemodynamic effects of acute and long term -blockade in angina pectoris.
    Sharma B; Taylor SH
    Br J Pharmacol; 1971 Oct; 43(2):470P-471P. PubMed ID: 4400578
    [No Abstract]   [Full Text] [Related]  

  • 22. Haemodynamic effects of Trasicor, a new beta-adrenergic blocking agent, in hypertensive patients.
    Eisalo A; Luomanmäki K; Heikkilä J
    Acta Med Scand; 1969; 186(1-2):105-10. PubMed ID: 5807637
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of immediate haemodynamic effects of three beta-adrenergic blocking agents.
    Rivier JL; Nissiotis E; Jaeger M
    Postgrad Med J; 1970 Nov; ():Suppl:44-9. PubMed ID: 4395457
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats.
    Parratt JR; Wadsworth RM
    Br J Pharmacol; 1970 May; 38(3):554-71. PubMed ID: 4392541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treadmill exercise in dogs under -adrenergic blockade: adaptation of coronary and systemic hemodynamics.
    Bassenge E; Kucharczyk M; Holtz J; Stoian D
    Pflugers Arch; 1972; 332(1):40-55. PubMed ID: 4401667
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of haemodynamic effects of oxprenolol (trasicor), alprenolol (aptin), and sotalol (MJ 1999) in man.
    Gibson DG; Hoy J; Sowton E
    Br Heart J; 1970 Jul; 32(4):553. PubMed ID: 4393535
    [No Abstract]   [Full Text] [Related]  

  • 27. The cardiac effects of tea.
    Gould L; Goswami MK; Reddy CV; Gomprecht RF
    J Clin Pharmacol; 1973; 13(11):469-74. PubMed ID: 4490670
    [No Abstract]   [Full Text] [Related]  

  • 28. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 29. Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.
    Franciosa JA; Freis ED; Conway J
    Circulation; 1973 Jul; 48(1):118-24. PubMed ID: 4150000
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular effects of M & B 17803A in man.
    Leary WP; Coleman AJ
    S Afr Med J; 1972 Aug; 46(34):1202-3. PubMed ID: 4403479
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of beta-adrenergic blockade with alprenolol on ST-segment depression and circulatory dynamics during exercise in patients with effort angina.
    Bailey IK; Anderson SD; Rozea PJ; Bernstein L; Nyberg G; Korner PI
    Am Heart J; 1976 Oct; 92(4):416-26. PubMed ID: 961582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What is assured in treatment with beta receptor blockaders?].
    von Egidy H
    Internist (Berl); 1972 Dec; 13(12):481-4. PubMed ID: 4405768
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects on the hemodynamics and myocardial contractility of 2 beta blockader agents: propranolol and proctolol].
    Sanguinetti M; Picchio FM; Maresta A; Branzi A; Baccarani G; Binetti G
    G Ital Cardiol; 1972; 2(5):710-9. PubMed ID: 4404053
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardio-circulatory effects of beta-adrenergic blockade in organic heart disease. Comparison between propranolol and CIBA 39,089-Ba.
    Grandjean T; Rivier JL
    Br Heart J; 1968 Jan; 30(1):50-9. PubMed ID: 5637558
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.
    Jewitt D; Birkhead J; Mitchell A; Dollery C
    Lancet; 1974 Aug; 2(7877):363-7. PubMed ID: 4136593
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of the cardiovascular actions of four adrenergic -receptor blocking agents in resting, conscious dogs.
    Bergamaschi M; Shanks RG; Caravaggi AM; Mandelli V
    Am Heart J; 1971 Sep; 82(3):338-51. PubMed ID: 4397985
    [No Abstract]   [Full Text] [Related]  

  • 37. Sympathetic control of coronary and systemic hemodynamics in emotional stress in the conscious dog.
    Bergamaschi M; Shanks RG; Mandelli V
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():399-407. PubMed ID: 4157080
    [No Abstract]   [Full Text] [Related]  

  • 38. Antihypertensive therapy with alprenolol, a beta-adrenergic receptor antagonist.
    Tibblin G; Ablad B
    Acta Med Scand; 1969 Nov; 186(5):451-7. PubMed ID: 4392231
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Gibson DG
    Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison between alprenolol and chlorthalidone as antihypertensive agents.
    Bengtsson C
    Acta Med Scand; 1972 May; 191(5):433-9. PubMed ID: 4555618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.